Effects of the serotonin-uptake inhibitor, fluoxetine, on immunoreactive serotonin innervation in the rat pituitary gland. 1987

L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
Department of Anatomy, University of New Mexico School of Medicine, Albuquerque 87131.

Serotonin (5-HT)-immunoreactive innervation can be demonstrated in both the pars intermedia and pars nervosa of the rat pituitary gland. Fluoxetine hydrochloride, a 5-HT uptake inhibitor, was administered in single or multiple doses to adult male Sprague-Dawley rats to examine the possibility that 5-HT present in pituitary fibers may be due to uptake of the indoleamine. Paraffin-embedded sections of pituitaries from fluoxetine-treated rats revealed diminution or loss of 5-HT fiber staining in the intermediate, but not in the neural lobe, in all animals examined. Multiple doses of fluoxetine produced the most consistent effects on immunostaining. These observations along with results of our previous studies suggest that the intermediate lobe innervation immunoreactive for 5-HT may be due to uptake of indoleamine from extrinsic sources, while the pars nervosa terminals containing 5-HT most likely originate from 5-HT neuronal perikarya in the lower brainstem or hypothalamus.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D012702 Serotonin Antagonists Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. 5-HT Antagonist,5-HT Antagonists,5-Hydroxytryptamine Antagonist,5-Hydroxytryptamine Antagonists,Antiserotonergic Agent,Antiserotonergic Agents,Serotonin Antagonist,Serotonin Blockader,Serotonin Blockaders,Serotonin Receptor Antagonist,Serotonin Receptor Blocker,Antagonists, 5-HT,Antagonists, 5-Hydroxytryptamine,Antagonists, Serotonin,Serotonin Receptor Antagonists,Serotonin Receptor Blockers,5 HT Antagonist,5 HT Antagonists,5 Hydroxytryptamine Antagonist,5 Hydroxytryptamine Antagonists,Agent, Antiserotonergic,Agents, Antiserotonergic,Antagonist, 5-HT,Antagonist, 5-Hydroxytryptamine,Antagonist, Serotonin,Antagonist, Serotonin Receptor,Antagonists, 5 HT,Antagonists, 5 Hydroxytryptamine,Antagonists, Serotonin Receptor,Blockader, Serotonin,Blockaders, Serotonin,Blocker, Serotonin Receptor,Blockers, Serotonin Receptor,Receptor Antagonist, Serotonin,Receptor Antagonists, Serotonin,Receptor Blocker, Serotonin,Receptor Blockers, Serotonin
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
July 1983, European journal of pharmacology,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
April 1978, Clinical pharmacology and therapeutics,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
January 1991, Medicinal research reviews,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
January 1985, Journal of neural transmission,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
May 1999, Cell and tissue research,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
June 1980, Endocrinology,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
January 1990, International clinical psychopharmacology,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
April 1996, Neuroscience letters,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
August 1979, Life sciences,
L C Saland, and J A Wallace, and E Reyes, and A Samora, and D Maez, and F Comunas
January 1988, Psychopharmacology,
Copied contents to your clipboard!